Earnings History Data for Meridian Bioscience (VIVO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Meridian Bioscience

Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
22-11-2022 PM VIVO Meridian Bioscience 1,401 0.20 0.15 0.00 Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M
[11/22/2022 8:46 AM]
31.68 -0.32 
(-1.00%)
32.70 0.70 
(2.19%)
17.20 - 34.38 321,308 270,000 22,985
06-05-2022 PM 8:00 AM ET
(May 6)
VIVO Meridian Bioscience Inc. 1,200 0.66 0.48 0.56 Meridian Bioscience Non-GAAP EPS of $0.66 beats by $0.19, revenue of $111.23M beats by $11.68M
[5/6/2022 8:07 AM]
26.22 -0.40 
(-1.50%)
26.22 0.0 
(0.00%)
17.00 - 28.72 229,573 360,000 13,517
04-02-2022 PM 7:30 AM ET
(Feb 4)
VIVO Meridian Bioscience Inc. 957.72 0.35 0.25 0.65 Meridian Bioscience Non-GAAP EPS of $0.35, revenue of $88.3M
[2/4/2022 8:06 AM]
23.99 2.61 
(12.18%)
22.50 1.12 
(5.24%)
17.00 - 30.65 1,064,341 860,000 3,759
12-11-2021 PM 8:00 AM ET
(Nov 12)
VIVO Meridian Bioscience Inc. 813.75 0.23 0.20 0.19 Meridian Bioscience EPS beats by $0.03, beats on revenue
[11/12/2021 7:32 AM]
20.70 1.36 
(7.03%)
20.10 0.76 
(3.93%)
15.93 - 30.65 726,094 280,000 4,645
06-08-2021 PM 7:30 AM ET
(Aug 6)
VIVO Meridian Bioscience Inc. 930.30 0.22 0.31 0.55 Meridian Bioscience EPS misses by $0.09, misses on revenue
[8/6/2021 8:17 AM]
20.67 -0.66 
(-3.09%)
19.50 -1.83 
(-8.58%)
12.98 - 30.65 565,072 400,000 493
07-05-2021 PM 7:30 AM ET
(May 7)
VIVO Meridian Bioscience Inc. 834.86 0.56 0.48 0.23 Meridian Bioscience EPS beats by $0.09, misses on revenue
[5/7/2021 7:34 AM]
20.45 1.28 
(6.68%)
20.45 0.0 
(0.00%)
12.98 - 30.65 965,244 570,000 50,927
05-02-2021 PM 7:30 AM ET
(Feb 5)
VIVO Meridian Bioscience Inc. 983.21 0.65 0.42 0.10 Meridian Bioscience EPS beats by $0.24, beats on revenue
[2/5/2021 7:32 AM]
29.10 5.48 
(23.20%)
24.76 1.14 
(4.83%)
5.51 - 29.23 2,555,044 491,381 26,933
13-11-2020 PM 7:30 AM ET
(Nov 13)
VIVO Meridian Bioscience Inc. 679.80 0.19 0.14 0.13 Meridian Bioscience EPS beats by $0.05, beats on revenue
[11/13/2020 7:31 AM]
16.90 0.73 
(4.51%)
17.04 0.87 
(5.38%)
5.51 - 26.58 935,382 603,882 7,601
07-08-2020 PM 7:30 AM ET
(Aug 7)
VIVO Meridian Bioscience Inc. 1,090 0.55 0.24 0.16 Meridian Bioscience EPS beats by $0.33, beats on revenue
[8/7/2020 7:32 AM]
20.82 -3.47 
(-14.29%)
25.45 1.16 
(4.78%)
5.51 - 26.58 1,376,282 551,802 33,411